Sio Capital Management’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-555,610
Closed -$3.48M 59
2022
Q4
$3.48M Hold
555,610
1.86% 17
2022
Q3
$1.95M Hold
555,610
0.83% 25
2022
Q2
$1.64M Sell
555,610
-6,729
-1% -$16.1K 0.65% 34
2022
Q1
$1.75M Hold
562,339
0.71% 40
2021
Q4
$1.9M Hold
562,339
0.58% 44
2021
Q3
$2.05M Hold
562,339
0.66% 43
2021
Q2
$2.45M Hold
562,339
0.67% 51
2021
Q1
$2.55M Sell
562,339
-25,000
-4% -$135K 0.53% 59
2020
Q4
$3.37M Sell
587,339
-571,897
-49% -$4.33M 0.74% 51
2020
Q3
$8.39M Sell
1,159,236
-1,140,746
-50% -$6.1M 1.86% 21
2020
Q2
$8.03M Buy
2,299,982
+2,167,508
+1,636% +$6.25M 2.48% 13
2020
Q1
$196K Buy
+132,474
New +$222K 0.07% 64
2019
Q2
Sell
-239,827
Closed -$3.19M 103
2019
Q1
$3.19M Buy
239,827
+52,500
+28% +$558K 0.97% 47
2018
Q4
$1.47M Buy
+187,327
New +$1.78M 0.57% 55
2017
Q4
Sell
-75,000
Closed -$605K 80
2017
Q3
$605K Buy
+75,000
New +$507K 0.48% 47
2015
Q1
Sell
-121,900
Closed -$1.2M 43
2014
Q4
$1.2M Buy
+121,900
New +$980K 0.94% 25

Other funds holding CBAY